Quality evidence is needed to support a new Medicare Part D medication therapy management (MTM) program performance measure, prompting a scoping review on MTM services and associated outcomes.
Am J Health Syst Pharm. 2006;63(19):1806-1809. This installment of the Medicare Modernization Act (MMA) Q&A describes pharmacists' use of a Web-based program to document and be reimbursed for ...